Stockscreener 앱 받기
1.21
1.63%
-0.02
시간 외 거래:
1.21
전일 마감가:
$1.23
열려 있는:
$1.25
하루 거래량:
42,704
Relative Volume:
0.02
시가총액:
$10.89M
수익:
$5.64M
순이익/손실:
$-23.88M
주가수익비율:
-2.283
EPS:
-0.53
순현금흐름:
$-22.36M
1주 성능:
+4.31%
1개월 성능:
-14.18%
6개월 성능:
-17.12%
1년 성능:
-70.12%
1일 변동 폭
$1.18
$1.25
1주일 범위
$1.1711
$1.36
52주 변동 폭
$0.95
$4.2899
Evogene Ltd Stock (EVGN) Company Profile
EVGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.21 | 10.89M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-08 | 개시 | ROTH Capital | Buy |
| 2021-07-29 | 개시 | Aegis Capital | Buy |
| 2020-12-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 개시 | Oppenheimer | Outperform |
Evogene Ltd 주식(EVGN)의 최신 뉴스
Evogene Ltd. stock daily chart insightsDownside Control Plan With Support Analysis - Newser
Evogene Ltd. recovery potential after sell offValue Investing Summary and Earnings Outlook - Newser
How Evogene Ltd. stock performs during market volatilityBuy and Hold Strategy for Capital Safety - Newser
Can Evogene Ltd. maintain sales growthSmart Entry for Explosive Returns - mustnews.co.kr
Will Evogene Ltd. see short term momentumWeekly Outlook for Short Term Investors - Newser
What MACD and RSI say about Evogene Ltd.ROI Focused Setup Screener With Exit Markers - Newser
Has Evogene Ltd. Stock Ever Crashed Historical Volatility ReviewDownside Control Plan With Support Analysis - Newser
Trapped Investors in Evogene Ltd. Await Breakout SignalVerified Signal From Chart Patterns Detected - beatles.ru
Published on: 2025-08-04 06:37:37 - Jammu Links News
What are Evogene Ltd. company’s key revenue driversCapitalize on emerging market trends - Jammu Links News
Is Evogene Ltd. stock overvalued or undervaluedAchieve consistent profits with expert strategies - Jammu Links News
What markets is EYEN expanding into Is Evogene Ltd. stock a good long term investment optionExtraordinary earning power - Jammu Links News
Does Evogene Ltd. stock perform well during market downturnsGet alerts on high-potential stock breakouts - Jammu Links News
What are the latest earnings results for Evogene Ltd.Build wealth faster with consistent growth stocks - Jammu Links News
What is the dividend policy of Evogene Ltd. stockUnstoppable investment returns - Jammu Links News
Should I hold or sell Evogene Ltd. stock in 2025Market-crushing stock picks - Jammu Links News
How many analysts rate Evogene Ltd. as a “Buy”Achieve consistent profits with disciplined trading - Jammu Links News
Is Evogene Ltd. a growth stock or a value stockStock Market Ideas With Proven Results - Jammu Links News
Evogene Schedules Second Quarter 2025 Financial Results Release - 富途牛牛
What risks could impact Evogene Ltd. stock performanceConsistent Profit Pattern Recognition Tools Shared - metal.it
What makes Evogene Ltd. stock price move sharplyEntry and Exit Strategy Optimizer Tool Tested - beatles.ru
Evogene Announces Q2 2025 Financial Results Release, Schedules Zoom Conference Call for August 19, 2025. - AInvest
Computational Biology Leader Evogene Sets Q2 2025 Earnings Release DateKey Details Inside - Stock Titan
How does Evogene Ltd. compare to its industry peersPre Market Trend Scanner From AI Tools - jammulinksnews.com
Evogene Ltd. Company Revenue and Profit Trends: A Deep DiveExpert Verified Stock Trade Ideas Backed by Data - metal.it
What markets is Evogene Ltd. expanding into Is SBCF stock a good long term investment optionMaximize returns with smart investment plans - Jammu Links News
Why is Evogene Ltd. stock attracting strong analyst attentionPhenomenal capital gains - Jammu Links News
Why Evogene Ltd. stock attracts strong analyst attentionFree Predictions - metal.it
Is Evogene Ltd. a good long term investmentRemarkable growth - PrintWeekIndia
Evogene Ltd. Stock Analysis and ForecastExplosive earning power - PrintWeekIndia
How Evogene Ltd. stock reacts to Fed policy changesRecord-setting profit potential - jammulinksnews.com
What drives Evogene Ltd. stock priceExceptional trading results - PrintWeekIndia
Evogene Ltd (EVGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):